We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$435M
AUM Growth
+$51.9M
Cap. Flow
+$45.2M
Cap. Flow %
10.4%
Top 10 Hldgs %
16.72%
Holding
755
New
324
Increased
103
Reduced
86
Closed
242

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$9.85M
2
MSFT icon
Microsoft
MSFT
+$8.89M
3
MRNA icon
Moderna
MRNA
+$8.13M
4
TSLA icon
Tesla
TSLA
+$7.08M
5
AMD icon
Advanced Micro Devices
AMD
+$6.43M

Sector Composition

Rank Sector Weight
1 Technology 25.48%
2 Consumer Discretionary 14.29%
3 Healthcare 13.77%
4 Communication Services 12.07%
5 Industrials 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMA
351
DELISTED
Comerica
CMA
$301K 0.07%
+4,200
New +$275K
LPSN icon
352
LivePerson
LPSN
$22M
$301K 0.07%
380
-367
-49% -$340K
BAP icon
353
Credicorp
BAP
$30.5B
$299K 0.07%
+2,193
New +$341K
CBRE icon
354
CBRE Group
CBRE
$43.3B
$293K 0.07%
+3,700
New +$262K
MDB icon
355
MongoDB
MDB
$25.8B
$293K 0.07%
+1,095
New +$388K
VSAT icon
356
Viasat
VSAT
$9.67B
$293K 0.07%
+6,100
New +$295K
NOC icon
357
Northrop Grumman
NOC
$76B
$291K 0.07%
+900
New +$271K
GATX icon
358
GATX Corp
GATX
$6.45B
$287K 0.07%
+3,097
New +$289K
PAAS icon
359
Pan American Silver
PAAS
$17.9B
$286K 0.07%
+9,536
New +$310K
KPTI icon
360
Karyopharm Therapeutics
KPTI
$155M
$284K 0.07%
+1,800
New +$379K
SAIL
361
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$284K 0.07%
5,600
-5,900
-51% -$332K
ACB
362
Aurora Cannabis
ACB
$169M
$280K 0.06%
3,010
-6,490
-68% -$725K
BALL icon
363
Ball Corp
BALL
$17.5B
$280K 0.06%
+3,300
New +$289K
NTES icon
364
NetEase
NTES
$83B
$279K 0.06%
+2,700
New +$306K
GPK icon
365
Graphic Packaging
GPK
$3.35B
$278K 0.06%
15,300
-7,102
-32% -$121K
EGO icon
366
Eldorado Gold
EGO
$8.33B
$276K 0.06%
+25,548
New +$302K
POLY
367
DELISTED
Plantronics, Inc.
POLY
$276K 0.06%
+7,090
New +$266K
NKTR icon
368
Nektar Therapeutics
NKTR
$2.39B
$275K 0.06%
918
-257
-22% -$80K
MDU icon
369
MDU Resources
MDU
$4.18B
$274K 0.06%
+22,814
New +$249K
IGV icon
370
iShares Expanded Tech-Software Sector ETF
IGV
$12.4B
$273K 0.06%
+4,000
New +$284K
BNS icon
371
Scotiabank
BNS
$105B
$272K 0.06%
+4,344
New +$252K
LH icon
372
Labcorp
LH
$25.2B
$272K 0.06%
+1,241
New +$249K
AMT icon
373
American Tower
AMT
$83.5B
$271K 0.06%
+1,134
New +$253K
DISCK
374
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$271K 0.06%
+7,347
New +$312K
SWI
375
DELISTED
SolarWinds Corporation Common Stock
SWI
$271K 0.06%
+14,738
New +$254K

Similar funds

Bayesian Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Bayesian Capital Management held 755 positions worth $435M, up 14% from $383M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Bayesian Capital Management deployed $45.2M of net new capital in Q1 2021, opening 324 new positions and adding to 103 existing holdings. Its largest new stake was Apple: 76,700 shares worth $9.37M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $10.6M trimmed.

  • Bayesian Capital Management's largest Q1 2021 buy was Apple: 76,700 shares worth $9.37M.
  • Bayesian Capital Management added most to Tesla in Q1 2021, an estimated $7.08M increase.
  • Bayesian Capital Management's biggest Q1 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $10.6M.
  • Bayesian Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $10.9M.
  • Bayesian Capital Management's ten largest holdings make up 17% of its $435M portfolio in Q1 2021.
  • Bayesian Capital Management opened 324 new positions and closed 242 in Q1 2021.
  • Bayesian Capital Management's portfolio value rose 14% quarter-over-quarter to $435M.

Based on Bayesian Capital Management's 13F filing for Q1 2021, filed 14 May 2021.